7:04 pm Amgen: Phase 3 DECISION Trial of NEXAVAR (sorafenib) in thyroid cancer refractory to radioactive iodine published in The Lancet
View todays social media effects on AMGN
View the latest stocks trending across Twitter. Click to view dashboard
See who Amgen is hiring next, click here to view
